This funding supports research to comprehensively characterize the natural history of disorders screened in newborns. Projects may include studying symptom development, genotype-phenotype correlations, and genetic or environmental modifiers. The goal is to improve diagnostic accuracy, facilitate clinical trials, develop targeted treatments, and establish longitudinal data systems or patient registries to support affected infants and families.
Eligible applicants include small businesses, nonprofits, academic institutions, tribal governments, state and local governments, and various other organizations including faith-based and community-based groups, federal agencies, and non-U.S. entities.
